High Variability of Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation

被引:20
作者
Sikma, Maaike A. [1 ,2 ]
Hunault, Claudine C. [3 ]
Van Maarseveen, Erik M. [4 ,5 ]
Huitema, Alwin D. R. [5 ,6 ]
Van de Graaf, Ed A. [7 ]
Kirkels, Johannes H. [8 ]
Verhaar, Marianne C. [9 ]
Grutters, Jan C. [7 ,10 ]
Kesecioglu, Jozef [11 ]
De Lange, Dylan W. [3 ,11 ]
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Dept Intens Care, F06-149,POB 85500, NL-3508 GA Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Dutch Poisons Informat Ctr, F06-149,POB 85500, NL-3508 GA Utrecht, Netherlands
[3] Univ Utrecht, Univ Med Ctr Utrecht, Dutch Poisons Informat Ctr, Utrecht, Netherlands
[4] Univ Utrecht, Univ Med Ctr Utrecht, Princess Maxima Ctr, Dept Clin Pharm, Utrecht, Netherlands
[5] Univ Utrecht, Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands
[6] Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands
[7] Univ Utrecht, Univ Med Ctr Utrecht, Dept Lung Transplantat, Utrecht, Netherlands
[8] Univ Utrecht, Univ Med Ctr Utrecht, Dept Cardiol, Heart Transplantat, Utrecht, Netherlands
[9] Univ Utrecht, Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands
[10] St Antonius Hosp, Dept Pulmonol, Utrecht, Netherlands
[11] Univ Utrecht, Univ Med Ctr Utrecht, Dept Intens Care, Utrecht, Netherlands
关键词
ACUTE KIDNEY INJURY; LIVER-TRANSPLANTATION; RENAL-TRANSPLANTATION; LUNG TRANSPLANTATION; DRUG-INTERACTIONS; TROUGH LEVELS; EARLY PERIOD; HEART; RECIPIENTS; EXPOSURE;
D O I
10.1007/s13318-019-00591-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Objective Oral tacrolimus is initiated perioperatively in heart and lung transplantation patients. There have been few studies on oral tacrolimus pharmacokinetics early post-transplantation, even though tacrolimus-related toxicity may occur early, potentially leading to morbidity and mortality. Therefore, we aimed to study the pharmacokinetics of oral tacrolimus in thoracic organ recipients during the first days after transplantation. Methods We conducted a pharmacokinetic study in 30 thoracic organ transplants at intensive care at the University Medical Center Utrecht in the first week post-transplantation. Twelve-hour whole-blood tacrolimus profiles were examined using high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) and analysed via population pharmacokinetic modelling. Results The concentration-time profiles showed high variability. Concentrations at 12 h were outside the target range in 69% of the cases. A two-compartment model with mixed first-order and zero-order absorption adequately described tacrolimus concentrations. The typical value of the apparent clearance was 19.6 L/h (95% CI 16.2-22.9), and the apparent distribution volumes of central and peripheral compartments, V1 and V2, were 231 L (95% CI 199-267) and 521 L (95% CI 441-634), respectively. Inter-occasion (dose-to-dose) variability far exceeded the interindividual variability (IIV), with an estimated variability in relative bioavailability of 55% (95% CI 48.5-64.4). Conclusions The high variability of tacrolimus pharmacokinetics early after thoracic organ transplantation is largely due to excessive variability in bioavailability, making individualised dosing based on measured concentrations futile. To bypass this bioavailability issue, we suggest administering tacrolimus intravenously and aiming below the upper therapeutic range early post-transplantation. Clinical Trial Registraion: NTR 3912/EudraCT 2012-001909-24.
引用
收藏
页码:123 / 134
页数:12
相关论文
共 56 条
  • [1] Therapeutic drug monitoring of tacrolimus in early stage after heart transplantation
    Aidong, W
    Zhenjie, C
    Tong, L
    Lei, Z
    Yin, W
    Shanqi, Z
    Liping, T
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (08) : 2388 - 2389
  • [2] Allosteric modulation of drug binding to human serum albumin
    Ascenzi, P
    Bocedi, A
    Notari, S
    Fanali, G
    Fesce, R
    Fasano, M
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (04) : 483 - 489
  • [3] Postoperative acute kidney injury in living donor liver transplantation recipients
    Atalan, Hakan K.
    Gucyetmez, Bulent
    Aslan, Serdar
    Yazar, Serafettin
    Polat, Kamil Y.
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2018, 41 (01) : 37 - 42
  • [4] Can initial tacrolimus trough levels be predicted from clinical variables?
    Baran, DA
    Galin, ID
    Zucker, MJ
    Alvi, S
    Arroyo, LH
    Lubitz, S
    Kaplan, S
    Correa, R
    Courtney, MC
    Chan, M
    Spielvogel, D
    Lansman, SL
    Gass, AL
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (09) : 2816 - 2818
  • [5] Predictors of early renal insufficiency in cardiac transplant recipients initiated on tacrolimus
    Baran, DA
    Galin, ID
    Sandler, D
    Cheng, J
    Segura, L
    Courtney, MC
    Correa, R
    Chan, M
    Lansman, SL
    Spielvogel, D
    Gass, AL
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1872 - 1873
  • [6] Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects
    Bekersky, I
    Dressler, D
    Mekki, QA
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (02) : 176 - 182
  • [7] Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
    Brunet, Merce
    van Gelder, Teun
    Asberg, Anders
    Haufroid, Vincent
    Hesselink, Dennis A.
    Langman, Loralie
    Lemaitre, Florian
    Marquet, Pierre
    Seger, Christoph
    Shipkova, Maria
    Vinks, Alexander
    Wallemacq, Pierre
    Wieland, Eberhard
    Woillard, Jean Baptiste
    Barten, Markus J.
    Budde, Klemens
    Colom, Helena
    Dieterlen, Maja-Theresa
    Elens, Laure
    Johnson-Davis, Kamisha L.
    Kunicki, Pawel K.
    MacPhee, Iain
    Masuda, Satohiro
    Mathew, Binu S.
    Millan, Olga
    Mizuno, Tomoyuki
    Moes, Dirk-Jan A. R.
    Monchaud, Caroline
    Noceti, Ofelia
    Pawinski, Tomasz
    Picard, Nicolas
    van Schaik, Ron
    Sommerer, Claudia
    Vethe, Nils Tore
    de Winter, Brenda
    Christians, Uwe
    Bergan, Stein
    [J]. THERAPEUTIC DRUG MONITORING, 2019, 41 (03) : 261 - 307
  • [8] Mechanisms of clinically relevant drug interactions associated with tacrolimus
    Christians, U
    Jacobsen, W
    Benet, LZ
    Lampen, A
    [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (11) : 813 - 851
  • [9] Sublingual Tacrolimus as an Alternative to Intravenous Route in Patients With Thoracic Transplant: A Retrospective Study
    Collin, C.
    Boussaud, V.
    Lefeuvre, S.
    Amrein, C.
    Glouzman, A. S.
    Havard, L.
    Billaud, E. M.
    Guillemain, R.
    [J]. TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) : 4331 - 4337
  • [10] Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit
    de Jonge, Hylke
    Vanhove, Thomas
    de Loor, Henriette
    Verbeke, Kristin
    Kuypers, Dirk R. J.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (03) : 548 - 559